Hyperfine
Guilford, Connecticut, United States · Biotechnology, Health Care, Health Diagnostics
Hyperfine, Inc. (Nasdaq: HYPR) is the groundbreaking medical technology company that created the Swoop® system, the world’s first FDA-cleared portable magnetic resonance imaging (MRI) system capable of providing brain imaging at the point of care. The Swoop® system received initial U.S. Food and Drug Administration (FDA) clearance in 2020 as a bedside magnetic resonance imaging device for producin
Key facts
- Headquarters
- Guilford, Connecticut, United States
- Employees
- 120
- Industries
- Biotechnology, Health Care, Health Diagnostics
- Status
- Public (HYPR)
- Website
- hyperfine.io
- Company page
Recent activity at Hyperfine
- : SEC 8-K (2.02): On October 8, 2026, Hyperfine, Inc. reported preliminary unaudited financial results for the quarter and nine months ended September 30, 2026. The company estimated total revenue of approximately $6.0 million for the quarter and $13.8 million for the nine months. Additionally, as of September 30, 2026, Hyperfine reported estimated cash and cash equivalents of around $37.9 million. These figures are subject to change as they are based on management's preliminary assessments and the completion of their financial processes.
- : SEC 8-K (5.01): On September 17, 2026, Hyperfine, Inc. received a notice from Nasdaq indicating that its Class A common stock has fallen below the minimum bid price of $1.00 for 30 consecutive business days, thus failing to meet the Nasdaq Listing Rule 5450(a)(1). This non-compliance notice does not have immediate implications for the listing or trading of the stock, which continues to trade on Nasdaq under the symbol 'HYPR'. However, it raises concerns regarding the company's compliance and potential strategies it may need to implement to regain compliance and avoid delisting. The situation is significant as it directly impacts investor confidence and could influence future capital raising efforts.
- : Hyperfine, Inc. launched the next generation Swoop® system, a portable MRI, generating strong market demand.
- : SEC 8-K (2.01): On October 15, 2025, Hyperfine, Inc. provided a preliminary update regarding its financial performance for the quarter ended September 30, 2025. The report disclosed estimated total revenues of approximately $3.4 million and cash and cash equivalents amounting to roughly $21.6 million as of the same date. These figures are preliminary and subject to finalization as part of the upcoming financial statements. This financial report indicates the company's business trajectory and operational health, which could impact investor perceptions and future fundraising efforts.
- : Hyperfine, Nvidia Partner To Make Brain MRIs More Affordable
- : Hyperfine, Inc. Announces CE Approval for AI-Powered Swoop® System Software to Enhance Portable Brain Imaging in Europe.
- : Hyperfine Expands European Market Reach with Additional Strategic Distributor Partners
- : Hyperfine, Inc. Appoints Enrico Barini as International Business Development Director
- : Hyperfine, Inc. Announces Promotion of Tom Teisseyre, Ph.D. to Chief Operating Officer
Leadership
- Enrico Barini, Director
- Tom Teisseyre, Chief Operating Officer
Verified email and direct lines for Hyperfine’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Employee benefit plans
Hyperfine files 1 employee benefit plan with the U.S. Department of Labor. The next plan year renews in Dec 2026.
Hyperfine in the news
- Hyperfine, Inc. to Announce Third Quarter 2026 Financial Results on November 9, 2026 - Business Wire (Oct 08, 2026)
- Stavanger University Hospital Installs Norway’s First Portable MRI Brain Imaging System from Hyperfine and Lioness Medtech - Cision News (Nov 12, 2025)
- Hyperfine, Inc. Reports Second Quarter 2026 Financial Results - Business Wire (Aug 06, 2026)
- Development of a mobile low-field MRI scanner - Scientific Reports - Nature (Apr 05, 2022)
- Hyperfine’s Portable MRI System Demonstrates High Accuracy for Detection of Brain Hemorrhage - Imaging Technology News (Sep 01, 2021)
- Hyperfine, Inc. Reports First Quarter 2026 Financial Results - Business Wire (May 12, 2026)
- Hyperfine, Inc. and the International Society for Magnetic Resonance in Medicine Collaborate to Enhance Global Access to MR Education - Imaging Technology News (Jun 13, 2023)
- New Yale Study Shows Portable MRI Cuts Time to Brain Imaging by 80% in the Emergency Department - Cision News (Jul 22, 2026)
Companies similar to Hyperfine
- Esaote Group · Biotechnology, Health Care, Health Diagnostics, Image Recognition, Information Technology, Medical Device, medical devices
- ImageCare Radiology · Biotechnology, Health Care, Health Diagnostics, Image Recognition, Medical Device
- Medical Informatics · Biotechnology, Health Care, Health Diagnostics, Information Technology, Medical Device
- Hope Care · Biotechnology, Health Care, Health Diagnostics, Information Technology, Medical Device
- Captive Radiology · Biotechnology, Health Care, Health Diagnostics, Image Recognition, Medical Device
About Hyperfine: questions and answers
What does Hyperfine do?
Hyperfine, Inc. (Nasdaq: HYPR) is the groundbreaking medical technology company that created the Swoop® system, the world’s first FDA-cleared portable magnetic resonance imaging (MRI) system capable of providing brain imaging at the point of care. The Swoop® system received initial U.S. Food and Drug Administration (FDA) clearance in 2020 as a bedside magnetic resonance imaging device for producin
Where is Hyperfine headquartered?
Hyperfine is headquartered in Guilford, Connecticut, United States.
How many employees does Hyperfine have?
Hyperfine has about 120 employees.
What is the latest news on Hyperfine?
On Oct 08, 2026, SEC 8-K (2.02): On October 8, 2026, Hyperfine, Inc. reported preliminary unaudited financial results for the quarter and nine months ended September 30, 2026. The company estimated total revenue of approximately $6.0 million for the quarter and $13.8 million for the nine months. Additionally, as of
Is Hyperfine a public company?
Yes. Hyperfine is publicly traded under the ticker HYPR.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy